✦ LIBER ✦

SERIAL MEASUREMENT OF GALECTIN-3 PREDICTS CHRONIC HEART FAILURE OUTCOMES AND VENTRICULAR REMODELING: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE THERAPY (PROTECT) STUDY

✍ Scribed by Motiwala, Shweta; Szymonifka, Jackie; Belcher, Arianna; Weiner, Rory; Baggish, Aaron; Sluss, Patrick; Gaggin, Hanna; Bhardwaj, Anju; Januzzi, James

Book ID: 122288850
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 200 KB
Volume: 61
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(13)60745-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serial measurement of galectin-3 in pati

Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study

✍ Motiwala, Shweta R.; Szymonifka, Jackie; Belcher, Arianna; Weiner, Rory B.; Bagg 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 143 KB

SERIAL MEASUREMENT OF INSULIN-LIKE GROWT

SERIAL MEASUREMENT OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 7 PREDICTS CHRONIC HEART FAILURE OUTCOMES AND VENTRICULAR REMODELING: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE THERAPY (PROTECT) STUDY

✍ Motiwala, Shweta; Bhardwaj, Anju; Szymonifka, Jackie; Belcher, Arianna; Weiner, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Quality of life and chronic heart failur

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study

✍ Anju Bhardwaj; Shafiq U. Rehman; Asim A. Mohammed; Hanna K. Gaggin; Linda Baraja 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Heart Failure Outcomes and Benefits of N

Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study

✍ Hanna K. Gaggin; Asim A. Mohammed; Anju Bhardwaj; Shafiq U. Rehman; Shawn A. Gre 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 452 KB

Characterization and Prediction of Adver

Characterization and Prediction of Adverse Events from Intensive Chronic Heart Failure Management with and without NT-proBNP Guidance: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study

✍ Gandhi, Parul U.; Szymonifka, Jackie; Motiwala, Shweta R.; Belcher, Arianna S.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 624 KB

DO ELDERLY PATIENTS WITH HEART FAILURE D

DO ELDERLY PATIENTS WITH HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION BENEFIT FROM NT-PROBNP-GUIDED HEART FAILURE MANAGEMENT? RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE THERAPY (PROTECT) STUDY

✍ Han-Na Kim; Asim A. Mohammed; Anju Bhardwaj; Shafiq Rehman; Shawn A. Gregory; Ju 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 261 KB